A stepwise approach for pharmacists in selecting climate-conscious inhaled therapy for COPD.
作者信息
Goldak Joyce, Tri Samantha, Roy Caitlin, Underwood Logan
机构信息
Saskatchewan Health Authority - Regina, Saskatchewan.
出版信息
Can Pharm J (Ott). 2024 Nov 15;158(1):12-19. doi: 10.1177/17151635241273754. eCollection 2025 Jan-Feb.
Abstract
摘要
相似文献
1
A stepwise approach for pharmacists in selecting climate-conscious inhaled therapy for COPD.药剂师为慢性阻塞性肺疾病（COPD）选择具有气候意识的吸入疗法的逐步方法。
Can Pharm J (Ott). 2024 Nov 15;158(1):12-19. doi: 10.1177/17151635241273754. eCollection 2025 Jan-Feb.
2
Are pharmacists reducing COPD'S impact through smoking cessation and assessing inhaled steroid use?药师是否通过戒烟和评估吸入性类固醇的使用来降低 COPD 的影响？
Respir Med. 2012 Feb;106(2):230-4. doi: 10.1016/j.rmed.2011.08.011. Epub 2011 Sep 7.
3
Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD.慢性阻塞性肺疾病（COPD）患者吸入给药系统选择时的患者因素考量与评估
Chest. 2024 Feb;165(2):323-332. doi: 10.1016/j.chest.2023.11.011. Epub 2023 Nov 15.
4
COPD 2013: an update on treatment and newly approved medications for pharmacists.COPD 2013：更新的治疗方法和新批准的药物供药剂师参考。
J Am Pharm Assoc (2003). 2013 Nov-Dec;53(6):e219-29; quiz e230-1. doi: 10.1331/JAPhA.2013.13535.
5
Climate-conscious pharmacy practice: An exploratory study of community pharmacists in Ontario.具有气候意识的药学实践：安大略省社区药剂师的探索性研究。
Can Pharm J (Ott). 2024 Sep 18;157(6):324-333. doi: 10.1177/17151635241267856. eCollection 2024 Nov-Dec.
6
A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review.吸入药物治疗稳定期慢性阻塞性肺疾病的逐步管理方法：综述
Respir Care. 2009 Aug;54(8):1058-81.
7
Development of a Self-Assessment Audit Instrument to Support Climate-Conscious Community Pharmacy Practice and Education.开发一种自我评估审计工具，以支持具有气候意识的社区药房实践与教育。
Pharmacy (Basel). 2023 Sep 29;11(5):158. doi: 10.3390/pharmacy11050158.
8
COPD: A stepwise or a hit hard approach?慢性阻塞性肺疾病：逐步治疗还是重拳出击？
Rev Port Pneumol (2006). 2016 Jul-Aug;22(4):214-21. doi: 10.1016/j.rppnen.2015.12.012. Epub 2016 Feb 27.
9
Impact of community pharmacists in COPD management: Inhalation technique and medication adherence.社区药剂师在慢性阻塞性肺疾病管理中的作用：吸入技术与药物依从性
Respir Med. 2016 Sep;118:22-30. doi: 10.1016/j.rmed.2016.07.010. Epub 2016 Jul 15.
10
Pharmacist Interventions for Inhaled Medication Use in Chronic Obstructive Pulmonary Disease (COPD).药师干预在慢性阻塞性肺疾病（COPD）中吸入药物的使用。
Sr Care Pharm. 2024 Nov 1;39(11):417-424. doi: 10.4140/TCP.n.2024.417.
本文引用的文献
1
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines Reviewed.《慢性阻塞性肺疾病全球倡议（GOLD）2023年指南》述评
Open Respir Med J. 2024 Jan 10;18:e18743064279064. doi: 10.2174/0118743064279064231227070344. eCollection 2024.
2
2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD.2023 加拿大胸科学会慢性阻塞性肺疾病稳定期患者药物治疗指南。
Chest. 2023 Nov;164(5):1159-1183. doi: 10.1016/j.chest.2023.08.014. Epub 2023 Sep 9.
3
Pressurized metered-dose inhalers and their impact on climate change.压力定量吸入器及其对气候变化的影响。
CMAJ. 2022 Mar 28;194(12):E460. doi: 10.1503/cmaj.211747.
4
Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England.切换至低全球变暖潜势吸入器的成本。基于英格兰国民保健服务处方数据的经济和碳足迹分析。
BMJ Open. 2019 Oct 29;9(10):e028763. doi: 10.1136/bmjopen-2018-028763.
5
Life cycle environmental emissions and health damages from the Canadian healthcare system: An economic-environmental-epidemiological analysis.加拿大医疗体系的生命周期环境排放与健康损害：一项经济-环境-流行病学分析。
PLoS Med. 2018 Jul 31;15(7):e1002623. doi: 10.1371/journal.pmed.1002623. eCollection 2018 Jul.
6
Guiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler Technique.引导吸气气流：In-Check DIAL G16的研发，一种改善吸入器技术的工具。
Pulm Med. 2017;2017:1495867. doi: 10.1155/2017/1495867. Epub 2017 Nov 16.
7
Device errors in asthma and COPD: systematic literature review and meta-analysis.哮喘和 COPD 中的器械错误：系统文献回顾和荟萃分析。
NPJ Prim Care Respir Med. 2017 Apr 3;27(1):22. doi: 10.1038/s41533-017-0016-z.
8
Impact of community pharmacists in COPD management: Inhalation technique and medication adherence.社区药剂师在慢性阻塞性肺疾病管理中的作用：吸入技术与药物依从性
Respir Med. 2016 Sep;118:22-30. doi: 10.1016/j.rmed.2016.07.010. Epub 2016 Jul 15.
9
Factors associated with undiagnosed and overdiagnosed COPD.与慢性阻塞性肺疾病未确诊和过度诊断相关的因素。
Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23.
10
Burden of chronic obstructive pulmonary disease: healthcare costs and beyond.慢性阻塞性肺疾病的负担：医疗费用及其他方面。
Allergy Asthma Proc. 2015 Jan-Feb;36(1):4-10. doi: 10.2500/aap.2015.36.3812.
Zotero 插件